Fertility preservation in pediatric solid tumors: A report from the Children's Oncology Group
Pediatric Blood & Cancer · 2024-06 · 71 (6)
DOI: 10.1002/pbc.30960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 26.03.2024. Verfasst von Kari Bjornard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, St. Baldrick's Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Treatment for childhood solid tumors may lead to an increased risk for gonadal dysfunction/infertility. Discussion of risk should occur at diagnosis, any changes in therapy, and during survivorship. Gonadotoxic therapies were abstracted from 32 Children's Oncology Group (COG) phase III, frontline solid tumor protocols, in use from 2000 to 2022. Risk for gonadal dysfunction/infertility was assessed based on gonadotoxic therapies, sex, and pubertal status and assigned as minimal , significant , and high following the Oncofertility Consortium Pediatric Initiative Network (PIN) risk stratification. Most protocols (65.6%, 21/32) contained at least one therapeutic arm with a high level of increased risk. Solid tumor therapies present challenges in risk stratification due to response‐adjusted therapy and the need to account for radiation field in the risk assessment. This guide hopes to serve as a tool to assist in standardizing gonadotoxic risk assessments across disciplines and improve referral for fertility services and reproductive health counseling for patients receiving COG‐based solid tumor therapy. Internationally, many solid tumor therapies follow similar paradigms to COG studies, and risk stratifications may be generalizable to similar styles of therapy. In addition, this model may be applied to other international groups with the goal of standardizing fertility assessments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, USA.
- Division of Hematology/Oncology, Helen DeVos Children's Hospital, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
- Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
- Division of Hematology/Oncology, Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.
- Fred Hutchinson Cancer Center, Seattle Children's Hospital, Seattle, Washington, USA.
ORCID-Profile: Kari Bjornard, Allison Close, Karen Burns
Förderung
- NCI NIH HHS
- St. Baldrick's Foundation
Zitieren
APA
Bjornard, K., Close, A., Burns, K., Chavez, J., Chow, E. J., & Meacham, L. R. (2024). Fertility preservation in pediatric solid tumors: A report from the Children's Oncology Group. Pediatric Blood & Cancer, 71(6). https://doi.org/10.1002/pbc.30960
Vancouver
Bjornard K, Close A, Burns K, Chavez J, Chow EJ, Meacham LR. Fertility preservation in pediatric solid tumors: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 2024;71(6). doi:10.1002/pbc.30960
BibTeX
@article{Bjornard2024,
author = {Bjornard, Kari and Close, Allison and Burns, Karen and Chavez, Josuah and Chow, Eric J and Meacham, Lillian R},
title = {Fertility preservation in pediatric solid tumors: A report from the Children's Oncology Group},
journal = {Pediatric Blood & Cancer},
year = {2024},
volume = {71},
number = {6},
doi = {10.1002/pbc.30960}
}
EUVIMED